• AJMCAJMC
  • Center for Biosimilars
Center for Biosimilars®
Center for Biosimilars®
Business Practice
View MoreBusinessDevelopmentLegalPolicyPracticeRegulatory
News
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Clinical
Dermatology
Endocrinology
Gastroenterology
Legal
Neurology
Oncology
Ophthalmology
Rare Disease
Rheumatology
Conferences
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Polls
Subscribe
  • About
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

© 2021 MJH Life Sciences and Center for Biosimilars®. All rights reserved.

Business PracticeSee All >
  • Business
  • Development
  • Legal
  • Policy
  • Practice
  • Regulatory
  • About
  • Contact
  • Advisory Board
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.

The Role of Biosimilars in Oncology

EP 1: Available Oncology Biosimilars and Their Efficacy

EP 2: What Are Biosimilars?

EP 3: Are Biosimilars and Biologics Similar?

EP 4: Can Biosimilars Be Switched?

EP 5: The FDA Approval of Biosimilars

EP 6: The FDA Pathway for Interchangeable Biosimilars

EP 7: Deciding Which Biosimilar to Use

EP 8: How Biosimilars Have Impacted Cancer Treatment

EP 9: Patient Access to Biosimilars

EP 10: The Economic Impact of Biosimilars

EP 11: The Role of Insurance Companies and PBMs on Biosimilar Access

EP 12: Formulary Inclusion for Biosimilars

EP 13: Biosimilar Challenges for Providers and Payers

EP 14: Educating Patients and Clinicians About Biosimilars